12:00 AM
 | 
Jan 28, 2013
 |  BC Week In Review  |  Company News  |  Deals

AstraZeneca, Lead Discovery Center deal

AstraZeneca and Lead Discovery Center partnered to discover and develop compounds to treat diseases with high unmet need. Under the two-year deal, AstraZeneca will add 250,000 of its compounds to Lead Discovery's internal screening...

Read the full 150 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >